Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
USD | Fiscal Year Ending | | Latest |
(in millions) | Dec-14 | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | Dec-22 | Dec-23 | | Sep-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 37 | 59 | 60 | 54 | 56 | 57 | 55 | 78 | 101 | 81 | | 72 |
% Growth | NA | 57.1% | 2.5% | -9.3% | 3.2% | 1.8% | -3.5% | 41.7% | 28.8% | -19.4% | | |
| | | | | | | | | | | | |
Cost of Revenue | (30) | (47) | (48) | (43) | (43) | (43) | (44) | (62) | (79) | (65) | | (56) |
Gross Profit | 7 | 12 | 12 | 11 | 13 | 14 | 11 | 17 | 22 | 16 | | 16 |
% Revenue | 19.7% | 20.4% | 20.1% | 20.9% | 23.2% | 24.5% | 19.8% | 21.3% | 21.9% | 19.3% | | 22.2% |
| | | | | | | | | | | | |
Research and Development | 0 | 0 | 0 | 0 | 0 | (1) | (2) | (2) | (2) | (2) | | (2) |
Selling and Marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
General and Admin | (7) | (11) | (11) | (10) | (14) | (14) | (16) | (22) | (28) | (23) | | (20) |
Other Inc / (Exp) | 0 | (2) | (2) | (2) | (3) | (2) | (2) | (3) | (3) | (17) | | (15) |
Total Operating Exp | (7) | (14) | (14) | (12) | (17) | (17) | (20) | (27) | (32) | (42) | | (37) |
| | | | | | | | | | | | |
Operating Income | (0) | (2) | (2) | (1) | (4) | (3) | (9) | (10) | (10) | (27) | | (21) |
% Revenue | -0.3% | -3.1% | -3.2% | -1.6% | -7.4% | -5.0% | -16.1% | -13.4% | -10.1% | -33.0% | | -29.7% |
| | | | | | | | | | | | |
Interest Expense | (1) | (1) | (5) | (2) | (2) | (3) | (3) | (3) | (3) | (3) | | (3) |
Pre-tax Income | (1) | (3) | (6) | (2) | (6) | (5) | (11) | (13) | (14) | (30) | | (25) |
Earnings of Discontinued Ops. | 0 | (0) | (7) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | 1 | 2 | (1) | 0 | 1 | (0) | (0) | (0) | 0 | 1 | | 0 |
Net Income to Company | 0 | (2) | (14) | (2) | (5) | (5) | (12) | (13) | (14) | (29) | | (24) |
% Margin | 0.8% | -2.9% | -23.9% | -4.5% | -9.3% | -9.5% | -20.8% | -16.8% | -13.5% | -36.2% | | -34.0% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0) | (0) | 0 | | 0 |
Net Income to Stockholders | 0 | (2) | (14) | (2) | (5) | (5) | (12) | (13) | (14) | (29) | | (24) |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | (0) | 0 | (0) | (0) | (0) | (0) | | (0) |
Other Adj. | 0 | 0 | 7 | 0 | 0 | 0 | 0 | 0 | (0) | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 0 | (1) | (7) | (2) | (5) | (5) | (12) | (13) | (14) | (29) | | (25) |
% Margin | 0.8% | -2.5% | -12.3% | -3.9% | -9.6% | -9.3% | -21.2% | -17.2% | -13.8% | -36.3% | | -34.1% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 0.18 | (0.82) | (4.11) | (1.20) | (2.18) | (1.37) | (2.71) | (2.21) | (1.83) | (3.50) | | (2.63) |
Diluted EPS (Continuing Ops) | 0.18 | (0.82) | (4.20) | (1.20) | (2.18) | (1.37) | (2.71) | (2.21) | (1.83) | (3.50) | | (2.63) |
| | | | | | | | | | | | |
WA Basic Shares Out. | 1.68 | 1.81 | 1.80 | 1.79 | 2.48 | 3.89 | 4.32 | 6.08 | 7.58 | 8.41 | | 11.32 |
WA Diluted Shares Out. | 2.27 | 1.81 | 1.80 | 1.79 | 2.48 | 3.89 | 4.32 | 6.08 | 7.58 | 8.41 | | 11.32 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | (1) | (3) | (6) | (2) | (6) | (5) | (11) | (13) | (14) | (30) | | (25) |
Addback: Net Interest Expense | 1 | 1 | 5 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | | 3 |
Addback: Other Non Operating Expenses, Total | (0) | 0 | (0) | (0) | 1 | 0 | (0) | (0) | 1 | 1 | | (1) |
Addback: Depreciation & Amortization | 0 | 3 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 2 | | 1 |
Addback: Restructuring Charges | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15 | | 15 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Assets | 0 | (0) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Asset Writedown | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | (0) | 0 | (0) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Adjusted EBITDA | (0) | 1 | 1 | 1 | (1) | (1) | (7) | (7) | (7) | (9) | | (6) |
% Margin | -0.4% | 0.9% | 1.0% | 1.6% | -2.1% | -1.2% | -12.1% | -9.0% | -7.4% | -11.6% | | -8.4% |
| | | | | | | | | | | | |
Adjusted EBIT | (0) | (2) | (1) | (1) | (3) | (3) | (9) | (10) | (10) | (12) | | (8) |
% Margin | -0.4% | -3.6% | -2.0% | -1.6% | -5.4% | -5.0% | -16.3% | -13.4% | -9.5% | -14.2% | | -10.5% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 0 | (2) | (14) | (2) | (5) | (5) | (12) | (13) | (14) | (29) | | (24) |
Addback: Unusual Items | 0 | (0) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 15 | | 15 |
Less: Tax Benefit of Unusual Items (26%) | (0) | 0 | (0) | (0) | 0 | 0 | 0 | 0 | 0 | (4) | | (4) |
Adjusted Net Income | 0 | (2) | (14) | (2) | (5) | (5) | (12) | (13) | (14) | (19) | | (14) |
% Margin | 0.8% | -3.4% | -22.8% | -4.4% | -9.3% | -9.5% | -20.8% | -16.8% | -13.5% | -22.9% | | -18.9% |